Geneva: World Health Organization and drug manufacturers Eli Lilly And the company is warning people to be careful Fake versions Popular weight loss and Diabetes medications, Who on Thursday said it had received multiple reports of counterfeit semaglutide — the active ingredient in Semaglutide. Novo Nordisk’Wegovy and Ozempic – in all geographic areas of the world from 2022.

Lilly said in an open letter that it was “deeply concerned” about rising online sales and social media posts that include fake or mixed versions. TirzepatideThe active ingredient behind its drugs Monjaro and Zepbound.

The Indianapolis-based company said it is the only legal supplier of these drugs, and that it does not make tirzepatide available to compounding pharmacies, wellness centers or online retailers.

Lilly said counterfeit versions of its drugs that are often advertised or sold online are never safe to use.

Novo Nordisk has issued similar warnings about its drugs in the past.

Who said Patients Patients can protect themselves by using prescriptions from licensed physicians to purchase medications. Patients should also avoid purchasing medications from unfamiliar sources, the agency said.

Lilly said none of the products marketed under the name tirzepatide, not Moanzaro or Zepabound, are made by the drugmaker or have been approved by the U.S. Food and Drug Administration. (AP)